Table 7.
Distribution of ROC test predicted values of changes of variables of clinical trials and changes of their characteristics after treatment and 1 month after treatment, according to groups of subjects
| Associated criterion | AUC [95% CI], % | Sensitivity/specificity [95% CI], % | Group III/group I+II, n (%) | Group III OR [95% CI] |
|---|---|---|---|---|
| Walking speed after treatment ≤ 0.025 m/s | 94,8 [85.4–97.1] |
93.3 [77.9–99.2] 87.1 [76.1–94.3] |
28 (93.3) 8 (12.9) |
94.5 [18.789–475.285] |
| Walking speed 1 months after treatment ≤ 0.05 m/s | 97.8 [92.4–99.8] |
93.3 [77.9–99.2] 96.7 [88.7–99.6] |
28 (93.3) 2 (3.3) |
413.0 [55.287–3085.16] |
| 5 sit downs/stand ups after treatment ≤ 1.92, s | 72.3 [61.9–81.2] |
69.0 [49.2–84.7] 77.4[65.0–87.1] |
20 (69.0) 14 (22.6) |
7.619 [2.841–20.434] |
| 5 sit downs/stand 1 month after treatment ≤ 2.75 s | 81.1 [71.5–88.6] |
65.5 [45.7–82.1] 86.9 [75.8–94.2] |
19 (65.5) 8 (13.1) |
12.587 [4.33–36.596] |
| Left leg | ||||
| Flexion range after treatment ≤ 4.0° | 82.0 [71.8–89.8] |
56.7 [37.4–74.5] 91.8 [80.4–97.7] |
17 (56.7) 4 (8.2) |
14.712 [4.207–51.445] |
| Flexion range 1 month after treatment ≤ 5° | 87.4 [77.9–93.8] |
70.0 [50.6–85.3] 83.3 [69.8–92.5] |
21 (70.0) 8 (16.7) |
11.667 [3.926–34.666] |
| Right leg | ||||
| Flexion range after treatment ≤ 10.0° | 82.7 [72.6–90.2] |
90.0 [73.5–97.9] 60.0 [45.2–73.6] |
27 (90.0) 20(40.0) |
13.5 [3.606–50.545] |
| Flexion range 1 month after treatment ≤ 12.0° | 88.0 [78.8–94.2] |
93.3 [77.9–99.2] 63.3 [48.3–76.6] |
28 (93.3) 18 (36.7) |
24.111 [5.13–113.333] |
| Left leg | ||||
| Flexor strength after treatment ≤ 0 score | 93.9 [86.1–98.0] |
100 [88.4–100] 89.8 [77.8–96.6] |
30 (100) 5 (10.2) |
– |
| Flexor strength 1 month after treatment ≤ 0 score | 93.8 [85.9–98.0] |
100 [88.4–100] 87.5 [74.8–95.3] |
30 (100) 6 (12.5) |
– |
| Right leg | ||||
| Flexor strength after treatment ≤ 0 score | 98.0 [91.9–99.8] |
100 [88.4–100] 95.9 [86.0–99.5] |
30 (100) 2 (4.1) |
– |
| Flexor strength 1 month after treatment ≤ .0 score | 94.9 [87.5–98.6] |
100 [88.4–100] 89.8 [77.8–96.6] |
30 (100) 5 (10.2) |
– |
| Left leg | ||||
| Extensor strength after treatment ≤ 0 score | 90.5 [81.8–95.9] |
93.3 [77.9–99.2] 85.7 [72.8–94.1] |
28 (23.3) 7 (14.3) |
84.0 [16.252–434.166] |
| Extensor strength 1 month after treatment ≤ 0 score | 89.5 [80.5–95.3] |
93.3 [77.9–99.2] 83.3 [69.8–92.5] |
28 (93.3) 8 (16.7) |
70.0 [13.811–354.781] |
| Right leg | ||||
| Extensor strength after treatment ≤ 0 score | 89.7 [80.6–95.5] |
93.3 [77.9–99.2] 87.0 [73.7–95.1] |
28 (93.3) 6 (13.0) |
93.333 [17.542–496.59] |
| Extensor strength 1 month after treatment ≤ .0 score | 87.0 [77.4–93.6] |
93.3 [77.9–99.2] 78.7 [64.3–89.3] |
28 (93.3) 10 (21.) |
51.8 [10.505–255.437] |
Group I, provided with bath procedures; group II, provided with mud procedures; group III, control; OR, odds ratio; CI, confidence interval; AUC, area under the ROC curve